NCT01835405已完成不适用
A Prospective, Single-centre Study to Compare the Use of LiquiBand® Flex, Dermabond Advanced™ or Conventional Sutures for the Topical Closure of Surgical Wounds
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 66
- 试验地点
- 2
- 主要终点
- To compare cosmetic outcomes at follow up
研究概览
简要总结
To evaluate the cosmetic outcome, effectiveness, user and subject satisfaction, and safety of LiquiBand® Flex in relation to DermaBond Advanced™ and conventional sutures for the topical closure of surgical wounds.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or Female aged 18 or older on day of enrollment
- •Scheduled for surgical procedure by a delegated study surgeon
- •Fresh surgical wound with evenly distributed tension over length of incision
- •Willing and able to sign informed consent
- •Agree to return for 2 week (+/- 7 days) and 3 month (90 days +/- 7 days) post-procedure follow-up visit
排除标准
- •Known sensitivity to cyanoacrylates, formaldehyde or acetone products
- •Wounds in which incision edges are under high tension or not easily apposed (after deep layer suture), or over joints (unless immobilized)
- •Wounds less than 15mm in length
- •Wounds in which haemostasis is not able to be achieved, eg, drain is placed or Warfarin level >2.5 prior to surgery
- •Wounds in which deep closure could not be achieved
- •Surgical procedures involving mucus membranes or eyes
- •Mental incapacity, dementia, or inability to give informed consent
- •Pregnant or nursing
- •Disease related or pharmacologically immuno-compromised
结局指标
主要结局
To compare cosmetic outcomes at follow up
时间窗: 3 months post treatment
Cosmesis to be evaluated by a panel of masked evaluators using a modified Hollander Wound Evaluation Scale
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Safety and Efficacy of Lip Injections With Emervel Lips and Juvederm Ultra SmileLocal Tolerability After Lip Filler InjectionsNCT01745250Galderma R&D40
已完成
2 期
BRIGHT-SC: Blisibimod Response in IgA Nephropathy Following At-Home Treatment by Subcutaneous AdministrationIgA NephropathyNCT02062684Anthera Pharmaceuticals57
已完成
3 期
CHABLIS-SC1: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus ErythematosusSystemic Lupus ErythematosusNCT01395745Anthera Pharmaceuticals442
已完成
2 期
Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies: Follow-up StudyHepatocellular CarcinomaNCT02745483Seoul National University Hospital153
招募中
不适用
Safety and Efficacy of Anti-BCMA-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MMRelapsed/Refractory Multiple MyelomaNCT06515262920th Hospital of Joint Logistics Support Force of People's Liberation Army of China10